Limited regression of central giant cell granuloma by interferon alpha after failed calcitonin therapy: a report of 2 cases

Authors
  • R.A.T. Gortzak
Publication date 2006
Journal International Journal of Oral and Maxillofacial Surgery
Volume | Issue number 35 | 9
Pages (from-to) 865-869
Organisations
  • Faculty of Dentistry (ACTA)
  • Faculty of Medicine (AMC-UvA)
Abstract
Central giant cell granuloma (CGCG) is a benign lesion of the jaws with a sometimes locally aggressive behaviour. The most common therapy is surgical curettage which has a high recurrence rate, especially in lesions with aggressive signs and symptoms (i.e. pain, paresthesia, root-resorption and rapid growth). Alternative therapies such as interferon alpha (INFα) or calcitonin are described in the literature. In this study 2 patients with an aggressive CGCG are presented who were treated with INF mono-therapy.
INF mono-therapy was capable of terminating the rapid growth of the lesion in both patients and induced a partial reduction. Total resolution, however, was not obtained and alternative treatment is still necessary.

Document type Article
Language English
Published at https://doi.org/10.1016/j.ijom.2006.02.011
Permalink to this page
Back